
Muramyl dipeptide
CAS No. 53678-77-6
Muramyl dipeptide ( MDP )
产品货号. M24521 CAS No. 53678-77-6
Muramyl 二肽是一种合成的免疫反应肽,由连接到 L-Ala-D-isoGln 短氨基酸链上的 N-乙酰胞壁酸组成。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥6391 | 有现货 |
![]() ![]() |
100MG | ¥8748 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Muramyl dipeptide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Muramyl 二肽是一种合成的免疫反应肽,由连接到 L-Ala-D-isoGln 短氨基酸链上的 N-乙酰胞壁酸组成。
-
产品描述Muramyl dipeptide is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Muramyl dipeptide indirectly decreases osteoclast differentiation through a decreased RANKL/OPG ratio. Muramyl dipeptide directly increases osteoblast differentiation by up-regulating Runx2 gene expression through MAPK pathways. Muramyl dipeptide is an inducer of bone formation through the induction of Runx2 .
-
体外实验Western Blot Analysis Cell Line:MC3T3-E1 cells Concentration:0.1, 1, 10 μg/mL Incubation Time:24 hours Result:Increased protein expression of Runx2 in a dose-dependent manner.RT-PCR Cell Line:MC3T3-E1 cells Concentration:0.1, 1, 10 μg/mL Incubation Time:6 hours Result:Increases mRNA levels of Runx2 in a dose-dependent manner.
-
体内实验Animal Model:RANKL-induced osteoporosis model (Five-week-old C57BL/6 mice)Dosage:1.25 mg/kg Administration: i.p.; twice (RANKL-induced osteoporosis for 3 weeks and euthanized at 4 weeks)Result:Significantly enhanced the trabecular bone volume (BV/TV) and trabecular number (Tb.N).
-
同义词MDP
-
通路MAPK/ERK Signaling
-
靶点ERK
-
受体ERK|JNK|p38 MAPK
-
研究领域——
-
适应症——
化学信息
-
CAS Number53678-77-6
-
分子量492.48
-
分子式C19H32N4O11
-
纯度>98% (HPLC)
-
溶解度DMSO:98 mg/mL (198.99 mM);Water:98 mg/mL (198.99 mM)
-
SMILESCC(N[C@@H]1[C@@H](OC(C(N[C@H](C(N[C@H](CCC(O)=O)C(N)=O)=O)C)=O)C)[C@H](O)[C@@H](CO)O[C@@H]1O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Park OJ, et al. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2. J Bone Miner Res. 2017 Jul;32(7):1455-1468.
产品手册




关联产品
-
GDC-0994
GDC-0994 是一种有效的口服 ERK1/2 抑制剂,IC50 分别为 1.1 nM 和 0.3 nM。
-
Patritumab
Patritumab (Human Anti-ERBB3 Recombinant Antibody) 是针对 ERBB3 的中和性单克隆抗体。Patritumab与 Cetuximab (HY-P9905) 具有协同作用,可有效抑制 EGFR,HER2,HER3,ERK 和 AKT 的磷酸化。Patritumab 也能诱导细胞凋亡 (apoptosis),也抑制胰腺、非小细胞肺癌和结直肠癌异种移植物肿瘤的生长。
-
Sec-O-Glucosylhamaud...
Sec-O-glucosylhamaudol 通过调节脂多糖刺激的 RAW264.7 细胞系中的 p38 丝裂原激活蛋白激酶而具有抗炎作用。